Hydroquinone vs Tranexamic Acid

Hydroquinone: Treats selected hyperpigmentation, including melasma, under an appropriate treatment plan. Tranexamic Acid: Topical formulas are studied for melasma, with mixed results.

Research updated 2026-10-25
Hydroquinone — Header ImageFive serums lined up on white, labeled tranexamic acid or niacinamide with TXA, including SkinCeuticals Discoloration Defense

Which one is right for you?

Choose Hydroquinone if…

Choose for diagnosed stubborn pigment with professional guidance and a defined review point.

  • Stubborn melasma or dark marks
  • A clinician is supervising
  • You can take breaks between courses

Choose Tranexamic Acid if…

Consider a topical pigment option; the evidence is mixed and formula-specific.

  • Melasma or stubborn dark marks
  • Skin that dislikes hydroquinone
  • Daily sunscreen
Often combined

Can you use both?

A common melasma pairing; tranexamic acid is gentle and can continue after hydroquinone stops.

At a glance

● Hydroquinone
● Tranexamic Acid
Type
Pigment-suppressing medicine
Pigment-targeting ingredient
What it does
Treats selected hyperpigmentation, including melasma, under an appropriate treatment plan.
Topical formulas are studied for melasma, with mixed results.
Best for
Melasma; Post-Inflammatory Hyperpigmentation; Sun Spots
Melasma
Studied concentrations
4% cream is a common prescription strength; local access rules vary.
Topical 5% in the cited trials; oral treatment is a separate medical decision.
When to use
On the schedule specified for the product or prescribed treatment.
On the schedule specified for the product or prescribed treatment.
Time to results
Usually assessed over 8–16 weeks
Usually assessed over 8–16 weeks
Irritation
Can irritate; prolonged inappropriate use can cause paradoxical darkening (ochronosis).
Can sting or cause redness; do not substitute tablets or injections for a cosmetic product.
Sensitive skin
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Available
Professional guidance; nonprescription hydroquinone skin-lightening products are not legally marketed in the US.
Prescription or cosmetic status depends on the active, formula and country; check the label.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Hydroquinone
Tranexamic Acid
Moderate evidenceSome supportive research
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Clinical trials support improvement with monitored topical treatment.
—
Limited evidenceEarly or small studies
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

Used for selected pigment after diagnosis; the cited trial studied melasma.
AI-generated educational illustration of Sun Spots: 1. Sun Spots Header — Light Skin; Lighter skin. Not a clinical photograph.

Sun Spots

May lighten selected benign spots; a changing lesion first needs diagnosis.
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Trials report mixed results, including one with no clear benefit over vehicle.
Insufficient evidence
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
A close crop of one lower eyelid and the top of the cheek on pale skin, no full face. The skin under the eye looks bluish-purple with fine veins showing, and a shallow hollow sits between the lid and the cheek.

Dark Circles Under the Eyes

The reviewed sources do not establish this ingredient as a treatment for this concern.
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trials do not establish benefit for all post-inflammatory pigment.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Post-Inflammatory Redness.

Post-Inflammatory Redness

The reviewed sources do not establish this ingredient as a treatment for this concern.
A relaxed forehead with faint shallow horizontal fine lines.

Wrinkles and Fine Lines

The reviewed sources do not establish this ingredient as a treatment for this concern.
How it works

Hydroquinone

Hydroquinone mechanism diagram. Acts on tyrosinase pathways: Hydroquinone suppresses melanin synthesis. Targets excess pigmentation: Appropriate use and monitoring matter.
Open full-size diagram
Diagram explanation and sources

Acts on tyrosinase pathways: Hydroquinone suppresses melanin synthesis. Targets excess pigmentation: Appropriate use and monitoring matter.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2

Tranexamic Acid

Tranexamic Acid mechanism diagram. Affects plasmin-related signaling: May reduce signals that stimulate pigment production. May help uneven pigmentation: Delivery and the formula influence topical results.
Open full-size diagram
Diagram explanation and sources

Affects plasmin-related signaling: May reduce signals that stimulate pigment production. May help uneven pigmentation: Delivery and the formula influence topical results.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning
Step 1
Cleanser
Step 2
Tranexamic AcidMorning or night
Step 3
Moisturizer
Step 4
Sunscreen
Night
Step 1
Cleanser
Step 2
HydroquinoneNight
Step 3
Tranexamic AcidMorning or night
Step 4
Moisturizer

Strengths and forms

Concentrations

4% is a common clinician-directed hydroquinone strength. In the U.S., hydroquinone skin-lightening products are not legally marketed over the counter; higher compounded strengths are not routine starting points.

4%

Clinician-directed strength

Used in melasma treatment and in the approved combination TRI-LUMA. Treatment length and the complete formula require medical guidance.

Choosing a strength: Get a diagnosis and a treatment plan for the pigmented area rather than choosing solely by concentration.

Higher strengths: More is not automatically better. Irritation and blue-black discoloration called ochronosis are important risks, especially with inappropriate or prolonged use.

Formula matters: Single-ingredient creams, compounded blends and TRI-LUMA are different products. A combination containing a steroid or retinoid needs its own instructions.

Topical tranexamic acid studies have used different delivery systems, including 1.8% liposomal lotion and 5% creams or solutions. Oral treatment and procedure-assisted delivery are separate medical decisions.

1.8%

5%

Studied liposomal lotion

One melasma trial tested this delivery system. Its percentage cannot be directly compared with an ordinary serum.

Studied topical formulas

Several melasma studies used topical formulas at this strength. Evidence does not establish one best concentration for all pigment concerns.

Choosing a strength: Look for evidence on the finished topical product. Do not use injectable or oral products as DIY skincare.

Higher strengths: A stronger topical percentage has not been shown to guarantee better results. Oral use requires separate evaluation of risks, including clotting risk.

Formula matters: Liposomal delivery, other brightening ingredients and procedures can change the treatment. A microneedling study is not evidence for the same result from a home serum.

Forms
Cream · Triple cream
Serum · Tablet · Injection

When you’ll see results

Approximate windows, not promises.

● Hydroquinone
● Tranexamic Acid
First few weeks

First few weeksAssess tolerance first; pigment change is usually slower.

First few weeksAssess tolerance first; pigment change is usually slower.

4–8 weeks

4–8 weeksSome studied regimens begin showing pigment improvement.

4–8 weeksSome studied regimens begin showing pigment improvement.

8–12 weeks

8–12 weeksA useful review point for benefit and irritation.

8–12 weeksA useful review point for benefit and irritation.

3–6 months

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

6–12 months

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

Safety and sensitive skin

Common reactions

Can irritate; prolonged inappropriate use can cause paradoxical darkening (ochronosis).

Can sting or cause redness; do not substitute tablets or injections for a cosmetic product.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Important limits

Do not use to lighten normal skin broadly or continue through worsening pigmentation. US nonprescription hydroquinone skin-lightening products are not legally marketed.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

More of it is absorbed through the skin than with most topicals, so it is usually stopped. Azelaic acid is the common substitute. Ask the doctor managing your pregnancy.

Melasma is common in pregnancy, so this comes up constantly. Oral tranexamic acid is not a casual pregnancy decision, and the topical version has little pregnancy-specific data. Ask the doctor managing your pregnancy, since they know your full picture.

How it works

In the skin

On the skin. The finished product delivers hydroquinone in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Suppresses melanin synthesis through tyrosinase-related activity; targeted use and monitoring matter.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers tranexamic acid in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. May affect plasmin-related signalling involved in pigmentation; a small molecular size does not guarantee delivery.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Molecule size
Hydroquinone · 110 Da
Tranexamic Acid · 157 Da
Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.
500 Da guideline

Product examples

Hydroquinone
  • Obagi Nu-Derm Sunfader
Tranexamic Acid
  • Anua Dark Spot Correcting Serum — 10% niacinamide and 4% tranexamic acid — a well-chosen pair of pigment actives at a fair price.
  • Naturium Tranexamic Topical Acid — 5% tranexamic acid with kojic acid and niacinamide, for $20. Well built, and no serum fixes melasma alone.

Common questions

Hydroquinone:What should I choose hydroquinone for?

Choose for diagnosed stubborn pigment with professional guidance and a defined review point.

Hydroquinone:How strong is the evidence?

The reviewed active-comparator melasma study was small with substantial attrition. Hydroquinone has broader clinical use, but this comparison does not support indefinite treatment or unsupervised high strengths.

Tranexamic Acid:What should I choose tranexamic acid for?

Consider a topical pigment option; the evidence is mixed and formula-specific.

Tranexamic Acid:How strong is the evidence?

A small vehicle-controlled 5% trial did not show superiority over vehicle. A larger active-comparator study found improvement in both groups but did not prove equivalence to hydroquinone.

Sources

Sources and further reading

  1. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial. (2021)
  2. FDA hydroquinone safety and access
  3. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. (2012)
  4. A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma. (2019)
  5. TRI-LUMA prescribing information
  6. Trial of 1.8% liposomal and procedure-assisted tranexamic acid
  7. Randomized trial of topical 5% tranexamic acid
Dermapedia on YouTube